Inosine Granules (肌苷颗粒)肌苷颗粒
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂
主要成分Active Ingredients
- 肌苷inosine
药物知识说明
肌苷是一种在国家药监局注册认定的药品。该药品含有肌苷-e3d74b2b等成分。
该药品关联的活性成分包括：肌苷inosine。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂。
您可以探索含有相同成分的其他药品：肌苷-e3d74b2b成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 肌苷颗粒) is a medicine registered with the national drug regulatory authority. It contains inosine as active ingredient(s).
Active ingredients associated with this product: 肌苷inosine.
Manufacturers recorded for this product: 海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂.
Explore other medicines containing the same ingredient: 肌苷 productsinosine products.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 肌苷颗粒Inosine Granules (肌苷颗粒)
- 剂型Dosage form: 颗粒剂Granules
- 规格Specification: 0.2g0.2 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20046209
关联实体Relationships
相关问题Questions
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20046209
Manufacturer
Chinese legal name: 海南制药厂有限公司制药一厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20046209
生产企业
海南制药厂有限公司制药一厂(国产)
适应症
用于急、慢性肝炎的辅助治疗。
用法用量
口服。成人一次1～2包，儿童一次0.5～1包，一日3次。温开水冲服。
不良反应
偶见胃部不适。
禁忌
对本品过敏者禁用，过敏体质者慎用。
注意事项
1.本品为肝病辅助治疗药，第一次使用本品前应咨询医师。治疗期间应定期到医院检查。
2.孕妇及哺乳期妇女应在医师指导下使用。
3.如服用过量或出现严重不良反应，应立即就医。
4.对本品过敏者禁用，过敏体质者慎用。
5.本品性状发生改变时禁止使用。
6.请将本品放在儿童不能接触的地方。
7.儿童必须在成人监护下使用。
8.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
密封，阴凉干燥处
规格
0.2g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.